| 1. |
- Ladenheim, D, et al.
(author)
-
Potential health risks of complementary alternative medicines in HIV patients.
- 2008
-
In: HIV Medicine. - : Wiley. - 1464-2662 .- 1468-1293. ; 9:8, s. 653-9
-
Journal article (peer-reviewed)abstract
- There are potentially significant health risks posed by the concomitant use of CAMs in patients taking ARV therapy. Medical practitioners need to be able to identify CAM use in HIV-positive patients and recognize potential health risks. Patients should be encouraged to disclose CAM use to their clinicians and other healthcare professionals.
|
|
| 2. |
- Lakhanpaul, Monica, et al.
(author)
-
An evidence-based guideline for children presenting with acute breathing difficulty
- 2009
-
In: Emergency Medicine Journal. - : BMJ. - 1472-0205 .- 1472-0213. ; 26:12, s. 850-853
-
Journal article (peer-reviewed)abstract
- We have developed an evidence-based guideline that has subsequently been successfully implemented in the paediatric emergency departments and disseminated nationally. Results showing the effect of the guideline upon practice will be published separately.
|
|
| 3. |
|
|
| 4. |
|
|
| 5. |
- Werneke, Ursula
(author)
-
Complementary medicines
- 2009
-
In: The New Oxford Textbook of Psychiatry, 2nd edition. - : Oxford University Press. - 9780199206698
-
Book chapter (other academic/artistic)
|
|
| 6. |
- Werneke, Ursula
(author)
-
Complementary medicines in mental health
- 2009
-
In: Evidence-Based Mental Health. - : BMJ Publishing Group Ltd. - 1362-0347 .- 1468-960X. ; 12:1, s. 1-4
-
Journal article (peer-reviewed)
|
|
| 7. |
|
|
| 8. |
- Werneke, Ursula
(author)
-
Withania somnifera : From Ayurveda towards Western medical practice: a systematic review
- 2009
-
In: Recent Progress in Medicinal Plants. - Houston : Studium Press LLC. - 9780976184959 ; , s. 237-256
-
Book chapter (other academic/artistic)abstract
- Withania somnifera (WS) has been used in ayurvedic medicine for more than 3000 years and has been implicated as of potential benefit for various somatic conditions. This study was conducted to define the potential of WS for further development and integration into the disease and symptom oriented Western medical system through systematic review of the Medline and Cochrane databases. The current evidence base on WS is currently limited to in vitro and animal experiments. The underlying mechanisms of action of WS identified seem to rely predominantly on antioxidant properties and stimulation of the cellular immune system. Thus, WS may potentially be of use as an adjunctive treatment of cancer, infections and inflammatory processes so far as stimulation of the immune system is desirable. WS may also be beneficial in the prevention or amelioration of neurodegenerative processes associated with oxidative stress as well as osteoarthritis. Although further proof of principle work is required, the development of WS as a disease oriented medicinal substance now requires well-designed clinical studies in humans.
|
|
